Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring

Saved in:
Bibliographic Details
Published in:JAC-Antimicrobial Resistance
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871837764332290048
collection WordPress RSS
FRELIP Feed Integration
container_title JAC-Antimicrobial Resistance
description
discipline_display Internal Medicine
discipline_facet Internal Medicine
format Online Article
RSS Article
genre Journal Article
id rss_article:106204
institution FRELIP
journal_source_facet JAC-Antimicrobial Resistance
last_indexed 2026-07-27T03:40:00.140Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
Internal Medicine
General
Internal Medicine
sub_discipline_display General
sub_discipline_facet General
subject_display Internal Medicine
General
Internal Medicine
subject_facet Internal Medicine
General
Internal Medicine
title Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_alt Oritavancina como terapia de consolidación o supresora en endocarditis infecciosa e infecciones relacionadas con dispositivos: experiencia real con monitorización terapéutica de fármacos
Oritavancine en traitement de consolidation ou suppressif dans l'endocardite infectieuse et les infections liées aux dispositifs : expérience réelle avec suivi thérapeutique médicamenteux
Oritavancina como terapia de consolidação ou supressiva na endocardite infecciosa e infeções relacionadas a dispositivos: experiência real com monitorização terapêutica de fármacos
title_auth Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_es_txt Oritavancina como terapia de consolidación o supresora en endocarditis infecciosa e infecciones relacionadas con dispositivos: experiencia real con monitorización terapéutica de fármacos
title_fr_txt Oritavancine en traitement de consolidation ou suppressif dans l'endocardite infectieuse et les infections liées aux dispositifs : expérience réelle avec suivi thérapeutique médicamenteux
title_full Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_fullStr Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_full_unstemmed Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_pt_txt Oritavancina como terapia de consolidação ou supressiva na endocardite infecciosa e infeções relacionadas a dispositivos: experiência real com monitorização terapêutica de fármacos
title_short Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
title_sort oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
topic Internal Medicine
General
Internal Medicine
url https://academic.oup.com/jacamr/article/doi/10.1093/jacamr/dlag150/8741257?rss=1